The data from Interim indicate safety of 70 percent, but researchers say that tweaking of the dose can be as high as 90 percent. The findings are perceived to be a positive, but they are coming after the 95% safety of Pfizer and Moderna vaccines. The Oxford Jab, though, is much quicker and easier to store and hit than the other two.
Thus if the vaccine is accepted for use by authorities, it would play a crucial part in fighting the pandemic.
“The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by the virus],” said Professor Sarah Gilbert, vaccine architect.
The UK Government has preordered Oxford vaccine for 100 million doses, and AstraZeneca claims it will be manufacturing three billion doses worldwide next year.
Prime Minister Boris Johnson has said “incredibly exciting news,” and these are great findings” even if security checks do have to be completed.”
Mr. Johnson added that the majority of the people in the UK most who want vaccine will get one by Easter, speaking at the Downing Street briefing on Monday evening.
And the Director of Oxford Vaccine Group, Professor Andrew Pollard, said it was a very exciting day and praised the 20,000 volunteers in trials around the world, with more than 10,000 of them in the UK.
What’s the reaction been?
“This is good news, we can clearly see the end of the tunnel now.” Peter Horby of Oxford University, however, was not involved in the trial. “We couldn’t see the end of the tunnel now.”
“That’s more outstanding news and can be incredibly inspiring, Dr. Stephen Griffin of Leeds University has enormous potential to be delivered across the world, offering huge benefits for public health.
Professor Chris Whitty, chief medical officer of England, has shared an “absolutely massive thank you” for his voluntary research at Covid-19.
He went on to state, “Because it’s science alone, as we have said many times, that’ll bring us forth from that hole.”